Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice
- 15 May 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 8 (8) , 1756-1766
Abstract
Crocus sativus, commonly known as saffron or Kesar, is used in Ayurveda and other folk medicines for various purposes as an aphrodisiac, antispasmodic, and expectorant. Previous evidence suggested that Crocus sativus is linked to improving cognitive function in Alzheimer’s disease (AD) patients. The aim of this study was to in vitro and in vivo investigate the mechanism(s) by which Crocus sativus exerts its positive effect against AD. The effect of Crocus sativus extract on Aβ load and related toxicity was evaluated. In vitro results showed that Crocus sativus extract increases the tightness of a cell-based blood-brain barrier (BBB) model and enhances transport of Aβ. Further in vivo studies confirmed the effect of Crocus sativus extract (50 mg/kg/day, added to mice diet) on the BBB tightness and function that was associated with reduced Aβ load and related pathological changes in 5XFAD mice used as an AD model. Reduced Aβ load could be explained, at least in part, by Crocus sativus extract effect to enhance Aβ clearance pathways including BBB clearance, enzymatic degradation and ApoE clearance pathway. Furthermore, Crocus sativus extract upregulated synaptic proteins and reduced neuroinflammation associated with Aβ pathology in the brains of 5XFAD mice. Crocin, a major active constituent of Crocus sativus and known for its antioxidant and anti-inflammatory effect, was also tested separately in vivo in 5XFAD mice. Crocin (10 mg/kg/day) was able to reduce Aβ load but to a lesser extent when compared to Crocus sativus extract. Collectively, findings from this study support the positive effect of Crocus sativus against AD by reducing Aβ pathological manifestations.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R15NS091934)
- Louisiana Board of Regents (LEQSF(2013-16)-RD-A-16)
This publication has 55 references indexed in Scilit:
- Immune attack: the role of inflammation in Alzheimer diseaseNature Reviews Neuroscience, 2015
- Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in miceExperimental Neurology, 2012
- Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's diseaseAlzheimer's Research & Therapy, 2012
- Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathologyJournal of the Neurological Sciences, 2010
- Alzheimer's disease: strategies for disease modificationNature Reviews Drug Discovery, 2010
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisalJournal of Neurochemistry, 2009
- Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats.2005
- ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoEJournal of Biological Chemistry, 2004
- Alterations in β-amyloid production and deposition in brain regions of two transgenic modelsNeurobiology of Aging, 2003
- Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivoBrain Research, 1999